Cargando…
Acute Infections and Inflammatory Biomarkers in Patients with Acute Pulmonary Embolism
Although infections are frequent in patients with pulmonary embolism (PE), its effect on adverse outcome risk remains unclear. We investigated the incidence and prognostic impact of infections requiring antibiotic treatment and of inflammatory biomarkers (C-reactive protein [CRP] and procalcitonin [...
Autores principales: | Eggers, Ann-Sophie, Hafian, Alaa, Lerchbaumer, Markus H., Hasenfuß, Gerd, Stangl, Karl, Pieske, Burkert, Lankeit, Mareike, Ebner, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219100/ https://www.ncbi.nlm.nih.gov/pubmed/37240652 http://dx.doi.org/10.3390/jcm12103546 |
Ejemplares similares
-
Long-term mortality in patients with pulmonary embolism: results in a single-center registry
por: Eckelt, Johannes, et al.
Publicado: (2023) -
Temporal trends in management and outcome of pulmonary embolism: a single-centre experience
por: Ebner, Matthias, et al.
Publicado: (2019) -
High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
por: Ebner, Matthias, et al.
Publicado: (2020) -
Outcome of patients with different clinical presentations of high-risk pulmonary embolism
por: Ebner, Matthias, et al.
Publicado: (2021) -
Prognostic value of right atrial dilation in patients with pulmonary embolism
por: Lerchbaumer, Markus H., et al.
Publicado: (2021)